Ethaselen (BBSKE), an inhibitor of thioredoxin reductase, is known to selectively kill cancer cells and many studies have suggested that BBSKE can interact with TrxR1 both in vitro and in vivo [29]. This evidence concerns the gene TXNRD1 and cancer.